Nanite
Nanite Bio is pioneering the future of genetic drug delivery with safe, resorbable polymer nanoparticles (PNPs). They combine AI-driven polymer design with multiplexed in vivo screening to develop tissue-specific delivery vectors, aiming to revolutionize gene therapy. Their mission is to solve the biggest hurdle in gene therapy—delivery—by harnessing AI and advanced materials science to create targeted, scalable, and safe gene delivery systems.
Industries
Nr. of Employees
small (1-50)
Products
Closed-loop AI-driven polymer nanoparticle design platform
An integrated platform that combines computational design, automated synthesis, first-principles characterization, high-content in vitro screening, multiplexed in vivo assays, and data pipelines to design and optimize polymer nanoparticles for targeted gene delivery.
Closed-loop AI-driven polymer nanoparticle design platform
An integrated platform that combines computational design, automated synthesis, first-principles characterization, high-content in vitro screening, multiplexed in vivo assays, and data pipelines to design and optimize polymer nanoparticles for targeted gene delivery.
Services
Custom development of polymer nanoparticle delivery vehicles
End-to-end development services including computational design, rapid synthesis, in vitro and in vivo screening, and characterization to produce tissue-specific polymer nanoparticle delivery candidates.
Collaborative research and translational partnerships
Partnership projects with external organizations and funders to apply AI-driven polymer design toward application-specific programs (examples include lung-targeting programs and HIV gene-therapy development partnerships).
Custom development of polymer nanoparticle delivery vehicles
End-to-end development services including computational design, rapid synthesis, in vitro and in vivo screening, and characterization to produce tissue-specific polymer nanoparticle delivery candidates.
Collaborative research and translational partnerships
Partnership projects with external organizations and funders to apply AI-driven polymer design toward application-specific programs (examples include lung-targeting programs and HIV gene-therapy development partnerships).
Expertise Areas
- Non-viral gene delivery
- Polymer nanoparticle engineering
- Machine learning-driven materials design
- High-throughput synthesis and screening
Key Technologies
- Machine learning for polymer design
- Closed-loop design–synthesis–test platforms
- High-throughput polymer synthesis automation
- High-content in vitro imaging and automated analysis